Clinical Trials Browser

Phase 1/2 × Nasopharyngeal Carcinoma × Cetuximab × Clear all

NCT01712919 2014-03-24

Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)

Phase 1/2 Completed

Nasopharyngeal Carcinoma